Literature DB >> 8445733

The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent.

B J Winslow1, D Trono.   

Abstract

Rodent cells present two blocks precluding the expression of the human immunodeficiency virus type 1 (HIV-1) genome. First, the viral protein Tat is only poorly active in these cells. Second, when the HIV-1 provirus is integrated in the genome of mouse cells, it electively fails to express the viral structural proteins, indicating a block to Rev action. Both defects can be complemented by fusion of the infected mouse cells with uninfected human cells. Because the production of high levels of Rev is dependent on Tat-mediated transactivation and because both Tat and Rev bind the viral transcript, it has been hypothesized that the two blocks found in rodent cells might be linked. In the present work, we demonstrate that overexpression of Rev in mouse cell lines does not relieve their block in HIV-1 structural-gene expression. In addition, we show that this defect is also present in human-mouse cell hybrids which contain human chromosome 12 and support Tat function. On that basis, we conclude that the blocks to HIV-1 Tat and Rev action in mouse cell lines are independent and result from the absence of distinct cellular elements that are critical for HIV-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445733      PMCID: PMC240394     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Tat and Rev: positive regulators of HIV gene expression.

Authors:  C A Rosen; G N Pavlakis
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

2.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

3.  Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells.

Authors:  S L Berberich; M Macias; L Zhang; L P Turek; C M Stoltzfus
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

6.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

Authors:  K A Page; N R Landau; D R Littman
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells.

Authors:  M Newstein; E J Stanbridge; G Casey; P R Shank
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.

Authors:  S Y Kim; R Byrn; J Groopman; D Baltimore
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.

Authors:  A I Dayton; E F Terwilliger; J Potz; M Kowalski; J G Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

10.  Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.

Authors:  C E Hart; C Y Ou; J C Galphin; J Moore; L T Bacheler; J J Wasmuth; S R Petteway; G Schochetman
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

View more
  23 in total

1.  The human T-cell leukemia virus type 1 Rex regulatory protein exhibits an impaired functionality in human lymphoblastoid Jurkat T cells.

Authors:  S Hamaia; H Cassé; L Gazzolo; M Duc Dodon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Authors:  Ryota Nakaoke; William A Banks
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

3.  Transgenic mice expressing human HIV receptors become persistently recipient of HIV DNA after injection with infected human cell lines.

Authors:  L Simeoni; P Forte; A Aiuti; A Candido; A F Campese; G Fedele; F Di Tommaso; M Navarra; A Fantoni
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

4.  A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Authors:  Mary Jane Potash; Wei Chao; Galina Bentsman; Nicolae Paris; Manisha Saini; Jadwiga Nitkiewicz; Paula Belem; Leroy Sharer; Andrew I Brooks; David J Volsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

5.  Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis.

Authors:  W A Banks; E O Freed; K M Wolf; S M Robinson; M Franko; V B Kumar
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in culture.

Authors:  Jadwiga Nitkiewicz; Wei Chao; Galina Bentsman; Jinliang Li; Seon-Young Kim; So Young Choi; Gabrielle Grunig; Harris Gelbard; Mary Jane Potash; David J Volsky
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

7.  High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.

Authors:  Hanna-Mari Tervo; Oliver T Keppler
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

8.  Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

Authors:  L Deml; A Bojak; S Steck; M Graf; J Wild; R Schirmbeck; H Wolf; R Wagner
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.

Authors:  R F Speck; M L Penn; J Wimmer; U Esser; B F Hague; T J Kindt; R E Atchison; M A Goldsmith
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element.

Authors:  G Nasioulas; S H Hughes; B K Felber; J M Whitcomb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.